Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response

References

• AntonijevicIADepressive disorders – is it time to endorse different pathophysiologies?Psychoneuroendocrinology200631111515950391
   PubMed Web of Science ®Google Scholar
• van PraagHMKraepelin, biological psychiatry, and beyondEur Arch Psychiatry Clin Neurosci2008258Suppl 2293218516514
   PubMed Web of Science ®Google Scholar
• LamersFde JongePNolenWAIdentifying depressive subtypes in a large cohort study: results from the Netherlands Study of Depression and Anxiety (NESDA)J Clin Psychiatry201071121582158920673552
   PubMed Web of Science ®Google Scholar
• AbelaJRSkitchSAAuerbachRPAdamsPThe impact of parental borderline personality disorder on vulnerability to depression in children of affectively ill parentsJ Pers Disord2005191688315899721
   PubMed Web of Science ®Google Scholar
• AriasBGutiérrezBPintorLGastóCFañanásLVariability in the 5-HT(2A) receptor gene is associated with seasonal pattern in major depressionMol Psychiatry20016223924211317230
   PubMed Web of Science ®Google Scholar
• CaspiASugdenKMoffittTEInfluence of life stress on depression: moderation by a polymorphism in the 5-HTT geneScience2003301563138638912869766
   PubMed Web of Science ®Google Scholar
• CookIAHunterAMAbramsMSiegmanBLeuchterAFMidline and right frontal brain function as a physiologic biomarker of remission in major depressionPsychiatry Res2009174215215719853417
   PubMed Web of Science ®Google Scholar
• JaworskaNProtznerAElectrocortical features of depression and their clinical utility in assessing antidepressant treatment outcomeCan J Psychiatry201358950951424099498
   PubMed Web of Science ®Google Scholar
• JaworskaNDe SommaEBlondeauCAuditory P3 in antidepressant pharmacotherapy treatment responders, non-responders and controlsEur Neuropsychopharmacol201323111561156923664712
   PubMed Web of Science ®Google Scholar
• KhanABrodheadAESchwartzKAKoltsRLBrownWASex differences in antidepressant response in recent antidepressant clinical trialsJ Clin Psychopharmacol200525431832416012273
   PubMed Web of Science ®Google Scholar
• MorishitaSAritaSDifferential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in genderEur Psychiatry200318841842014680720
   PubMed Web of Science ®Google Scholar
• MorishitaSKinoshitaTPredictors of response to sertraline in patients with major depressionHum Psychopharmacol200823864765118821727
   PubMed Web of Science ®Google Scholar
• InagakiTFuruyaMKawamukaiTPrediction of response within the first 3 days to treatment with paroxetine for depressionPrim Care Companion J Clin Psychiatry200810212913218458726
   PubMedGoogle Scholar
• NakajimaSUchidaHSuzukiTIs switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trialProg Neuropsychopharmacol Biol Psychiatry20113581983198921889560
   PubMed Web of Science ®Google Scholar
• HenkelVSeemüllerFObermeierMDoes early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depressionJ Affect Disord2009115343944919027961
   PubMed Web of Science ®Google Scholar
• KokRMvan BaarsenCNolenWAHeerenTJEarly response as predictor of final remission in elderly depressed patientsInt J Geriatr Psychiatry200924111299130319322797
   PubMed Web of Science ®Google Scholar
• LinCHLaneHYChenCCJuoSHYenCFEarly prediction of fluoxetine response for Han Chinese inpatients with major depressive disorderJ Clin Psychopharmacol201131218719321346612
   PubMed Web of Science ®Google Scholar
• MontgomerySAAsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry1979134382389444788
   PubMed Web of Science ®Google Scholar
• TakahashiNTomitaKHiguchiTInadaTThe inter-rater reliability of the Japanese version of the Montgomery-Asberg depression rating scale (MADRS) using a structured interview guide for MADRS (SIGMA)Hum Psychopharmacol200419318719215079853
   PubMed Web of Science ®Google Scholar
• LingjaerdeOAhlforsUGBechPDenckerSJElgenKThe UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patientsActa Psychiatr Scand Suppl198733411002887090
   PubMedGoogle Scholar
• BurrowsGDMcIntyreIMJuddFKNormanTRClinical effects of serotonin reuptake inhibitors in the treatment of depressive illnessJ Clin Psychiatry198849Suppl18223045107
   PubMed Web of Science ®Google Scholar
• TrivediMHCorey-LislePKGuoZLennoxRDPikalovAKimERemission, response without remission, and nonresponse in major depressive disorder: impact on functioningInt Clin Psychopharmacol200924313313819318972
   PubMed Web of Science ®Google Scholar
• BlierPGobbiGTurcotteJEMirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiationEur Neuropsychopharmacol200919745746519345072
   PubMed Web of Science ®Google Scholar
• Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric AssociationAm J Psychiatry2000157Suppl 4145
   Web of Science ®Google Scholar
• KornsteinSGSchatzbergAFThaseMEGender differences in treatment response to sertraline versus imipramine in chronic depressionAm J Psychiatry200015791445145210964861
   PubMed Web of Science ®Google Scholar
• YoungEAKornsteinSGMarcusSMSex differences in response to citalopram: a STAR*D reportJ Psychiatr Res200943550351118752809
   PubMed Web of Science ®Google Scholar
• ErnstCAngstJThe Zurich Study. XII: Sex differences in depression. Evidence from longitudinal epidemiological dataEur Arch Psychiatry Clin Neurosci19922412222301576178
   PubMed Web of Science ®Google Scholar
• KendlerKSThorntonLMGardnerCOStressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesisAm J Psychiatry200015781243125110910786
   PubMed Web of Science ®Google Scholar
• KesslerRCMcGonagleKASwartzMBlazerDGNelsonCBSex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrenceJ Affect Disord1993292–385968300981
   PubMed Web of Science ®Google Scholar
• Del GiudiceMBoothTIrwingPThe distance between Mars and Venus: measuring global sex differences in personalityPLoS One201271e2926522238596
   PubMed Web of Science ®Google Scholar
• JovanovicHLundbergJKarlssonPSex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PETNeuroimage20083931408141918036835
   PubMed Web of Science ®Google Scholar
• ParseyRVOquendoMASimpsonNREffects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635Brain Res2002954217318212414100
   PubMed Web of Science ®Google Scholar
• BetheaCLLuNZGundlahCStreicherJMDiverse actions of ovarian steroids in the serotonin neural systemFront Neuroendocrinol20022314110011906203
   PubMed Web of Science ®Google Scholar
• HiguchiHSatoKNaitoSDifferential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patientsNeuropsychiatr Dis Treat2009515115519557109
   PubMed Web of Science ®Google Scholar
• MorishitaSAritaSDifferential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to ageHum Psychopharmacol200419640540815303244
   PubMed Web of Science ®Google Scholar